← Back to XTLB

XTL Biopharmaceuticals Ltd. - American Depositary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2022Filed 24/08/2022Jun 2021Filed 24/08/2022Jun 2020Filed 24/08/2021
−$0.3−$1.2−$1.1
−$0.00−$0.00

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.